Cetacaine Topical Anesthetic Spray

Cetacaine Spray Sell Sheet
Click here to download
Cetacaine Spray
Product Sheet

Cannula Sterilization
Click here to download
Cannula Sterilization PDF

Cetacaine MSDS
Click here to
request MSDS

Product Catalog
Click here to download
Product Catalog

Topical Anesthetics
  • Delivers precise, controlled spray
  • Suppresses the gag reflex
  • Jetco® autoclavable stainless-
    steel cannula firmly attaches to the spray bottle
  • Onset within 30-60 seconds and duration is typically 30-60 minutes
  • Long history of safety when used as directed
  • Malleable cannula shape can be modified per physician preference or to accommodate anatomical requirements or procedures
  • Up to 100 doses per bottle
  • Pleasant tropical flavoring
  • Several cannula lengths
  • Only $0.79 a dose

Cetacaine Topical Anesthetic Spray is a fast-acting, long-lasting prescription topical anesthetic that permits direct application to the required site. Cetacaine Spray’s triple-active formula (Benzocaine 14.0 %, Butamben 2.0 %, Tetracaine Hydrochloride 2.0 %) is indicated for suppressing the gag reflex, controlling pain and easing discomfort during dental and medical procedures. Cetacaine Topical Anesthetic Spray is indicated for uses on all accessible mucosal membrane except the eyes.

Cetacaine is also available in liquid and gel forms.
Rx only.

Important Safety Information
On rare occasions, methemoglobinemia has been reported in connection with the use of benzocaine-containing products. Care should be used not to exceed the maximum recommended dosage. If a patient becomes cyanotic, treat appropriately to counteract (such as with methylene blue, if medically indicated). The most common adverse reaction caused by local anesthetics is contact dermatitis characterized by erythema and pruritus that may progress to vesiculation and oozing. This occurs most commonly in patients following prolonged self-medication, which is contraindicated.

Cetacaine is not right for everyone, including those who are hypersensitive to any of its ingredients or are known to have cholinesterase deficiencies. Please see the brief summary of the Prescribing Information on page six.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Contraindications:
Active Ingredients: Benzocaine 14.0 %, Butamben 2.0 %, Tetracaine Hydrochloride 2.0 %

Hypersensitivity Reactions: Unpredictable adverse reactions (i.e. hypersensitivity, including anaphalaxis) are extremely rare. Localized allergic reactions may occur after prolonged or repeated use of any aminobenzoate anesthetic. The most common adverse reaction caused by local anesthetics is contact dermatitis characterized by erythema and pruritus that may progress to vesiculation and oozing. This occurs most commonly in patients following prolonged self-medication, which is contraindicated. If rash, urticaria, edema, or other manifestations of allergy develop during use, the drug should be discontinued. To minimize the possibility of a serious allergic reaction, Cetacaine preparations should not be applied for prolonged periods except under continual supervision. Dehydration of the epithelium or an escharotic effect may also result from prolonged contact.

Precaution: On rare occasions, methemoglobinemia has been reported in connection with the use of benzocaine-containing products. Care should be used not to exceed the maximum recommended dosage (see Dosage and Administration). If a patient becomes cyanotic, treat appropriately to counteract (such as with methylene blue, if medically indicated).

Use in Pregnancy: Safe use of Cetacaine has not been established with respect to possible adverse effects upon fetal development. Therefore, Cetacaine should not be used during early pregnancy, unless in the judgment of a physician, the potential benefits outweigh the unknown hazards.

Contraindications: Cetacaine is not suitable and should never be used for injection. Do not use in eyes. To avoid excessive systemic absorption, Cetacaine should not be applied to large areas of denuded or inflamed tissue. Cetacaine should not be administered to patients who are hypersensitive to any of its ingredients or to patients known to have cholinesterase deficiencies. Tolerance may vary with the status of the patient. Cetacaine should not be used under dentures or cotton rolls, as retention of the active ingredients under a denture or cotton roll could possibly cause an escharotic effect. Routine precaution for the use of any topical anesthetic should be observed when using Cetacaine.